Denis Chem Lab Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Denis Chem Lab Ltd is ₹ 77 as of 05 May 15:30 . The P/E Ratio of Denis Chem Lab Ltd changed from 22.9 on March 2021 to 15.9 on March 2025 . This represents a CAGR of -7.04% over 5 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Denis Chem Lab Ltd changed from ₹ 51.83 crore on March 2021 to ₹ 128.57 crore on March 2025 . This represents a CAGR of 19.93% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 years The revenue of Denis Chem Lab Ltd for the Dec '25 is ₹ 45.96 crore as compare to the Sep '25 revenue of ₹ 46.82 crore. This represent the decline of -1.84% The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 33.93 crore as compare to the Sep '25 revenue of ₹ 14.25 crore. This represent the growth of 138.11% The ebitda of Denis Chem Lab Ltd for the Dec '25 is ₹ 6.46 crore as compare to the Sep '25 ebitda of ₹ 4.91 crore. This represent the growth of 31.57% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ -4.08 crore as compare to the Sep '25 ebitda of ₹ -4.63 crore. This represent the decline of -11.88% The net profit of Denis Chem Lab Ltd changed from ₹ 2.08 crore to ₹ 3.32 crore over 7 quarters. This represents a CAGR of 30.63% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -4.84 crore over 7 quarters. This represents a CAGR of 106.55% The Dividend Payout of Denis Chem Lab Ltd changed from 46.06 % on March 2021 to 25.77 % on March 2025 . This represents a CAGR of -10.97% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Denis Chem Lab Ltd

Denis Chem Lab Ltd, was incorporated in 1980 and was converted into a Public Limited Company in 1982.
The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology. The Company is a manufacturer of antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti anaerobic injections, irrigation solutions etc.
It is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles.
The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms.

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

FAQs for the comparison of Denis Chem Lab Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Denis Chem Lab Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Denis Chem Lab Ltd is 106 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 210 Cr

What are the key factors driving the stock performance of Denis Chem Lab Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Denis Chem Lab Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Denis Chem Lab Ltd and Oxygenta Pharmaceutical Ltd?

As of May 5, 2026, the Denis Chem Lab Ltd stock price is INR ₹77.0. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹56.89.

How do dividend payouts of Denis Chem Lab Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Denis Chem Lab Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.